Floatz logo

Therapeutic Asset Ratings

548 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Penpulimab
Advanced Solid Tumor
AkesoP1/2CC (45)
prj1-3024
Advanced Solid Tumor
Zhuhai Yufan Biotechnologies Co., LtdP1/2CC (45)
qlp2117
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
Rezatapopt
Advanced Solid Tumor
PMV Pharmaceuticals, IncP1/2CC (45)
Serplulimab
Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd.P1/2CC (45)
Simmitinib
Advanced Solid Tumor
Shanghai Runshi Pharmaceutical Technology Co., LtdP1/2CC (45)
sy-5933
Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTDP1/2CC (45)
T-Dxd
Advanced Solid Tumor
Daiichi SankyoP1/2CC (45)
tqb2618
Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1/2CC (45)
Vsv
Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (45)
yl201
Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd.P1/2CC (45)
Repotrectinib
Advanced Solid Tumor
Turning Point Therapeutics, Inc.P1/2CC (44)
Son-1010
Advanced Solid Tumor
Sonnet BioTherapeuticsP1/2CC (44)
Incb099280
Advanced Solid Tumor
Incyte CorporationP2CC (42)
DYNAMOS
Advanced Solid Tumor
Turning Point Therapeutics, Inc.P1CC (42)
REPAGLINIDE
Advanced Solid Tumor
PMV Pharmaceuticals, IncP1CC (42)
Camonsertib
Advanced Solid Tumor
Debiopharm International SAP1/2CC (42)
Infigratinib
Advanced Solid Tumor
Helsinn Healthcare SAP1/2CC (42)
Jab-21822
Advanced Solid Tumor
Jacobio Pharmaceuticals Co., Ltd.P1/2CC (42)
Vilastobart
Advanced Solid Tumor
Xilio Development, Inc.P1/2CC (42)
xtx202
Advanced Solid Tumor
Xilio Development, Inc.P1/2CC (42)
Tovorafenib
Advanced Solid Tumor
Day One Biopharmaceuticals, Inc.P2CC (40)
[111in]-fpi-1967
Advanced Solid Tumor
Fusion Pharmaceuticals Inc.P1/2CC (40)
[225Ac]-FPI-1966
Advanced Solid Tumor
Fusion Pharmaceuticals Inc.P1/2CC (40)
64cu-grip b
Advanced Solid Tumor
Rahul AggarwalP1/2CC (40)
Showing 101 to 125 of 548 assets
PreviousPage 5 of 22Next